Supported Online Self-Help for Veterans With Depression in Primary Care (SOS-Depression)
Supported Online Self-Help for Veterans With Depression in Primary Care (SOS-Depression)
調査の概要
状態
条件
詳細な説明
Background: VA's Primary Care-Mental Health Integration (PCMHI) is rooted in evidence-based collaborative care models, where care managers, mental health specialists, and primary care providers jointly treat depression in primary care. While PCMHI enabled specialists to support medication treatment in primary care, access to psychotherapy is not timely and sufficient. Alternative therapy modalities are needed. Peer-supported cCBT for depression has been shown to be effective but is not yet widely used within VA.
Significance/Impact: Depression is disabling and affects one in five Veterans. Psychotherapy is preferred by Veterans, but fraught with multilevel barriers (e.g., staff availability, patient travel to clinic, limited clinic hours). Without enhancing existing PCMHI models to enable better primary care patient access to effective psychotherapies, Veteran engagement in depression treatment is unlikely to improve.
Innovation: This study aims to close the gap in psychotherapy access for VA primary care patients with depression by adapting PCMHI collaborative care models to improve uptake of peer-supported computerized cognitive behavioral therapy (cCBT). cCBT is accessible 24/7 via the internet and has effectively treated depression in more than 30 trials. With peer specialist support, it is comparable to face-to-face psychotherapy. Peer support specialists and PCMHI teams can facilitate Veteran uptake of cCBT, using an evidence-based collaborative care model to provide the follow-up care management and mental health specialist back-up that characterizes the most effective cCBT trials.
Specific Aims/Methodology: This study involves 400 recent military service members and Veterans in VA Greater Los Angeles and San Diego. VA providers help service members undergoing discharge at military treatment facilities transition to the VA for care. Once at the VA, providers screen patients every year for depression. This randomized clinical trial will study the implementation and effectiveness of online therapy for depression. First, to help providers deliver and monitor online treatment, we will use three tested strategies for implementation: facilitators/coaches, quality improvement, and data monitoring/dashboards. Second, we will randomly assign patients who are newly diagnosed with depression to receive either: 1) online therapy supported by Veterans peers and VA PCMHI clinical teams (SOS-D intervention), or 2) online therapy supported by VA PCMHI clinical teams alone (enhanced usual care). Our research team will measure and compare depressive symptoms at the study start then at 3 months and 6 months across both groups. We will measure how much online therapy is used by each group. Third, through interviews we will compare the experiences of women Veterans and patients with TBI using online therapy to men Veterans and those without TBI.
Next Steps/Implementation: This research will demonstrate how online depression treatment can be given to military service members, Veterans, and civilians on a larger scale. Bringing Veteran peers onto VA clinical teams can enhance use of online therapy for depression and support Veteran recovery. Ensuring depression treatment is available immediately when needs are identified is important in preventing suicide.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Lucinda B Leung, MD, PhD, MPH
- 電話番号:310-267-7780
- メール:sos.depression@mednet.ucla.edu
研究場所
-
-
California
-
San Diego、California、アメリカ、92161
- VA San Diego Healthcare System
-
West Los Angeles、California、アメリカ、90073-1003
- VA Greater Los Angeles Healthcare System
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Must be enrolled in the VHA and currently receiving primary care services at VA Los Angeles or San Diego
- Have access to computer (mobile or desktop), internet, telephone, and email
- Able to read English text on a computer screen
- Score 10 or higher on the PHQ-9
Exclusion Criteria:
- Have moderate-high suicide risk (e.g. suicide flag) or active suicidality
- Have other serious mental illness (e.g. bipolar disorder, psychosis)
- Have medical disorder that would prevent/ interfere with participation (e.g. dementia/cognitive impairment, terminal illness)
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:ヘルスサービス研究
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:Enhanced Usual Care (EUC)
Participants in the enhanced usual care arm will receive access to computerized cognitive behavioral therapy (cCBT) supported by a care manager in addition to the usual care provided.
|
Enhanced usual care includes all the usual depression care at the VA and access to an online therapy program with no peer support sessions.
The online therapy program offered consists of several modules for depression care, specifically tailored for Veterans.
|
|
実験的:Supported Online Self-help for Depression (SOS-Depression)
Participants in the intervention arm will receive computerized cognitive behavioral therapy (cCBT) supported by a care manager and a designated Peer support specialist in addition to the usual care provided.
|
Supported Online Self-help for Depression (SOS-Depression) includes all the usual depression care at the VA and access to an online therapy program with support sessions with a peer.
The online therapy program consists of several modules for depression care, specifically tailored for Veterans.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Patient Health Questionnaire (PHQ-9)
時間枠:3- and 6-month follow up
|
The Patient Health Questionnaire (PHQ-9) is a scale commonly used to measure and categorize depression symptoms.
It is already administered as part of routine primary care at our study site.
The minimum score is 0, the maximum is 27.
A higher score indicates a worse outcome (i.e. more severe depression symptoms).
|
3- and 6-month follow up
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Behavioral Activation for Depression Scale (BADS-SF)
時間枠:3- and 6-month follow up
|
The 9-item Behavioral Activation for Depression Scale (BADS-SF) will also be used to examine behavioral activation as an intermediary to depression symptomatology outcomes.
The minimum score is 0, the maximum is 54.
Higher scores indicate a better outcome (i.e., higher activation).
|
3- and 6-month follow up
|
|
Generalized Anxiety Disorder (GAD-7)
時間枠:3- and 6-month follow up
|
The 7-item Generalized Anxiety Disorder (GAD-7) is among the most commonly used and best validated anxiety measures in primary care settings.
The minimum score is 0, the maximum is 21.
Higher scores indicate a worse outcome (i.e., more severe anxiety).
For reference: scores of 0-4=minimal anxiety, 5-9=mild anxiety, 10-14=moderate anxiety, and 15-21=severe anxiety.
|
3- and 6-month follow up
|
|
World Health Organization Disability Assessment Schedule (WHODAS 2.0)
時間枠:3- and 6-month follow up
|
The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) 12-item version is a brief self-report measure that will be used to assess functioning and disability across multiple domains of daily life.
The minimum score is 0, and the maximum score is 48.
Higher scores indicate greater disability.
|
3- and 6-month follow up
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Treatment Engagement
時間枠:6-months
|
Treatment engagement will be conceptualized as the number of cCBT sessions completed.
A higher number indicates more cCBT sessions completed, but isn't indicative of a better or worse outcome.
|
6-months
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- IRB-25-0799
- HT9425-25-1-0831 (その他の助成金/資金番号:Congressionally Directed Medical Research Programs (CDMRP))
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
The data collected during this clinical trial will be made available to the research community by depositing de-identified data into the NIMH Data Archive (NDA). All of the NIMH Common Data Elements (CDEs) will be collected for this study, following the NIMH expectations. In addition to the CDEs required by the NDA, we will also submit data elements covering demographics and health outcomes, healthcare services use, and satisfaction. We will use NIH-endorsed CDEs when possible.
- Sex
- Marital status
- Ethnicity
- Race
- Level of education
- Work status
- Housing status
- Behavioral Activation for Depression Scale (BADS-SF)
- Alcohol Use Disorders Identification Test (AUDIT-C)
- Columbia-Suicide Severity Rating Scale (C-SSRS)
- Posttraumatic Stress Disorder (PTSD) Checklist for DSM-5
- Client Satisfaction Questionnaire (CSQ-I)
- System Usability Scale (SUS)
IPD 共有時間枠
IPD 共有アクセス基準
UCLA is committed to the ideals of collaborative research, and as such, will adhere to the sponsors Grant Policy on Sharing of Unique Research Resources. The data collected for this research represent a valuable resource to the scientific community, and we will undertake all reasonable procedures to make them accessible to others, while respecting the special needs for confidentiality. The data collected during this clinical trial will be made available to the research community by depositing de-identified data into the NIMH Data Archive (NDA).
The NDA houses, harmonizes, and shares all human-subjects data collected as part of NIMH-funded projects with the goal of accelerating progress in the research of mental health. NDA is one database infrastructure that supports efforts to make data collected by different laboratories as consistent as possible and allow other researchers to access those data for secondary use. NDA stores and shares clinical/phenotypic, imaging, genomic, and othe
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。